US pursues about $13billion in Purdue opioid claims

US prosecutors are pursuing possible penalties of almost $13billion to resolve investigations of OxyContin maker Purdue Pharma after uncovering evidence of criminal and civil misconduct stemming from the company’s alleged role in fueling the opioid crisis. Officials outlined additional details of investigations in paperwork filed last week with a federal bankruptcy court.